Taubman Institute leaders published in "Academic Medicine" journal
The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.
The article, Transforming Science Into Medicine: How Clinician-Scientists Can Build Bridges Across Research's 'Valley of Death," explores the problematic gap between bench research and clinical application of new treatments or cures. Despite significant increases in National Institutes of Health spending on medical research, this 'valley of death' persists.
That's due to the declining role of clinician-scientists, the authors state, noting the percentage of M.D.s receiving NIH funding has declined compared with Ph.Ds. The dearth requires radical action, including greater funding for translational research and more resources for the training, debt relief and early-career support of potential clinician-scientists.
The authors of the article are:
- Dr. Eva Feldman, director, A. Alfred Taubman Medical Research Institute
- Martin A. Fischhoff, managing director, A. Alfred Taubman Medical Research Institute
- Dr. Stacey Sakowski, deputy managing director, A. Alfred Taubman Medical Research Institute
- Scott Roberts, J.D., Dickinson Wright PLLC
Click here to read the entire article.
Stem cell symposium set for Sept. 19 in Ann Arbor
Dr. Eva Feldman will be among the speakers at the one-day event, which focuses on cutting-edge developments in stem-cell biology, epigenetics and regneratrive medicine.
Click here for details and registration.
New Emerging Scholar named
Scott Tomlins, M.D., an assistant profesor of pathology at U-M, has been designated the A. Alfred Taubman Emerging Scholar. Dr. Tomlins is an expert in prostate cancer research.
People who care
Institute welcomes new gift officer
Maria Muller has been appointed to work with connect donors with funding opportunities at the Taubman Institute.
Click here to read more.
news & events
Institute symposium set for Oct. 10
The A. Alfred Taubman Medical Research Institute will award the 2014 $100,000 Taubman Prize for Excellence in Translational Medical Science at its 7th annual symposium at 10 a.m. on Oct. 10.
Dr. Carl June, a physician-scientist who developed a personalized immunotherapy for leukemia using patients’ own T cells, will receive the honor and deliver the symposium's keynote address.
Click here for symposium details.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D., is the lead author of a new study that finds a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Study: Two types of cancer stem cells lead to metastasis
Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to a new study published by Taubman Senior Scholar Dr. Max Wicha.